摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-乙酰基-4-氯噻吩 | 34730-20-6

中文名称
2-乙酰基-4-氯噻吩
中文别名
2-乙酰基-4-氯噻吩,98+%
英文名称
2-acetyl-4-chlorothiophene
英文别名
1-(4-chlorothiophen-2-yl)ethanone;1-(4-chlorothiophen-2-yl)ethan-1-one;1-(4-chloro-2-thienyl)ethanone
2-乙酰基-4-氯噻吩化学式
CAS
34730-20-6
化学式
C6H5ClOS
mdl
MFCD00082791
分子量
160.624
InChiKey
FKESGQASARHBDC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    263.0±25.0 °C(Predicted)
  • 密度:
    1.334

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    45.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险等级:
    6.1
  • 安全说明:
    S26
  • 危险类别码:
    R36
  • 海关编码:
    2934999090
  • 储存条件:
    2-8°C

SDS

SDS:6bbab692bccfad1bb82243f357baf096
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Acetyl-4-chlorothiophene
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H331: Toxic if inhaled
H302: Harmful if swallowed
H312: Harmful in contact with skin
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P311: Call a POISON CENTER or doctor/physician
P405: Store locked up

Section 3. Composition/information on ingredients.
Ingredient name: 2-Acetyl-4-chlorothiophene
CAS number: 34730-20-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H5ClOS
Molecular weight: 160.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN2810 Class: 6.1 Packing group: III
Proper shipping name: TOXIC, LIQUIDS, ORGANIC, N.O.S. OR TOXIC, LIQUIDS, ORGANIC, N.O.S. INHALA-
TION HAZARD, PACKING GROUP I, ZONE A OR B (2-Acetyl-4-chlorothiophene)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-乙酰基-4-氯噻吩copper(ll) bromide 作用下, 以 乙酸乙酯 为溶剂, 生成 2-溴-1-(4-氯噻吩-2-基)乙烷-1-酮
    参考文献:
    名称:
    含2-羰基噻吩的苯并呋喃衍生物的合成、杀线虫评价及SAR研究
    摘要:
    植物寄生线虫是作物保护的主要威胁。缺乏具有新作用方式和增加的抗性的杀线虫剂提高了对新型杀线虫剂的需求。为了寻找新的杀线虫先导物,从查耳酮的结构出发,通过闭环设计策略得到了一系列稠环化合物。这些化合物被进一步修饰。评估了合成化合物对南方根结线虫的杀线虫活性。生物测定表明,化合物3及其一些衍生物如化合物18、19、21、22、23、24和26表现出优异的杀线虫活性。其中,化合物23表现出显着的生物活性。LC 50/72 小时体外值达到3.20 mg/L ,在基质中40 mg/L时抑制率为100.00%。详细讨论了合成化合物的构效关系。还评估了化合物23对秀丽隐杆线虫的卵孵化、运动和摄食行为的影响。
    DOI:
    10.1016/j.cclet.2022.107800
  • 作为产物:
    描述:
    2-乙酰基噻吩 在 aluminum (III) chloride 、 三氯异氰尿酸 作用下, 以 二氯甲烷 为溶剂, 反应 4.0h, 以82.48%的产率得到2-乙酰基-4-氯噻吩
    参考文献:
    名称:
    一种4-氯噻吩-2-羰基衍生物的合成方法
    摘要:
    本发明公开了一种4‑氯噻吩‑2‑羰基衍生物的合成方法,以噻吩‑2‑羰基衍生物为原料,与三氯异氰尿酸和三氯化铝进行反应,分液,浓缩得4‑氯噻吩‑2‑羰基衍生物。本发明为一步反应,收率不低于80%,提高收率的同时减少生产工序,降低成本;所用原料和试剂易得,反应条件温和,后处理及纯化易于操作,可以大规模生产。
    公开号:
    CN109369611B
  • 作为试剂:
    描述:
    2-乙酰基噻吩三氯化铝 、 、 盐酸Sodium sulfate-III2-乙酰基-4-氯噻吩2-乙酰基-4,5-二氯噻吩 作用下, 以 氯仿 为溶剂, 反应 1.0h, 以yielding 4-chloro-2-acetylthiophene (31 g, 83% pure, 80% yield)的产率得到2-乙酰基-4-氯噻吩
    参考文献:
    名称:
    Thiophenyl triazol-3-one derivatives as smooth muscle relaxants
    摘要:
    本发明提供了一种新型的[1,2,4]三唑-3-酮衍生物,其具有一般式(I),其中:Q为,R1、R2、R3、R4、R5和R6如本文所定义,或其无毒药学上可接受的盐或溶剂,它们是平滑肌松弛剂,并且在治疗对平滑肌松弛有反应的疾病,如哮喘、肠易激综合征、男性勃起功能障碍和尿失禁方面有用。
    公开号:
    US06613786B2
点击查看最新优质反应信息

文献信息

  • Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
    申请人:N30 Pharmaceuticals, Inc.
    公开号:US09138427B2
    公开(公告)日:2015-09-22
    The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
    本发明涉及S-亚硝基谷胱甘肽还原酶(GSNOR)的抑制剂,包括这种GSNOR抑制剂的药物组合物,以及制备和使用这些药物的方法。
  • [EN] 2-METHYL-QUINAZOLINES<br/>[FR] 2-MÉTHYL-QUINAZOLINES
    申请人:BAYER PHARMA AG
    公开号:WO2018172250A1
    公开(公告)日:2018-09-27
    The present invention describes 2-methyl-quinazoline compounds of general formula (I), methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions. The 2-methyl substituted quinazoline compounds of general formula(I) effectively and selectively inhibit the Ras-Sos interaction without significantly targeting the EGFR receptor. They are therefore useful for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, such as cancer as a sole agent or in combination with other active ingredients.
    本发明描述了一般式(I)的2-甲基喹唑啉化合物,制备该化合物的方法,用于制备该化合物的中间体化合物,包含该化合物的药物组合物和组合物,以及用于制造药物组合物的该化合物的用途。一般式(I)的2-甲基取代喹唑啉化合物有效且选择性地抑制Ras-Sos相互作用,而不显著靶向EGFR受体。因此,它们对于治疗或预防疾病特别是高增殖性疾病,如癌症作为单一药剂或与其他活性成分组合使用是有用的。
  • Palladium-catalyzed direct 5-arylation of formyl- or acetyl-halothiophene derivatives
    作者:Kassem Beydoun、Henri Doucet
    DOI:10.1016/j.jorganchem.2010.12.021
    日期:2011.5
    found to catalyze the direct arylation of some functionalized halothiophene derivatives allowing the synthesis in only one step of polyfunctionalized arylated thiophenes. In the presence of 2-acetyl-3-chlorothiophene, 2-acetyl-4-chlorothiophene, 2-acetyl-3-bromothiophene diethylacetal or 2-(4-bromothiophen-2-yl)-[1,3]dioxolane, and a variety of aryl bromides, the 5-arylation products were obtained
    发现Pd(OAc)2催化某些官能化卤代噻吩衍生物的直接芳基化,仅一步合成多官能化芳基噻吩。在2-乙酰基-3-氯噻吩,2-乙酰基-4-氯噻吩,2-乙酰基-3-溴噻吩二乙基缩醛或2-(4-溴噻吩-2-基)-[1,3]二氧戊环存在下在使用多种芳基溴化物的情况下,仅使用0.5摩尔%的催化剂即可以中等至高收率获得5-芳基化产物。另一方面,使用2-甲酰基-3-氯噻吩,2-乙酰基-3-溴噻吩或2-甲酰基-3-溴噻吩的结果令人失望。
  • Cyclopentyl Methyl Ether: An Alternative Solvent for Palladium-Catalyzed Direct Arylation of Heteroaromatics
    作者:Kassem Beydoun、Henri Doucet
    DOI:10.1002/cssc.201000405
    日期:2011.4.18
    Some ethers, such as cyclopentyl methyl ether and di‐n‐butyl ether, which can be considered as “greener” solvents than N,N‐dimethylacetamide (DMAc) or DMF, can be advantageously employed for the palladium‐catalyzed direct arylation of heteroaromatics. In the presence of such ethers and only 0.5–1 mol % of palladium catalysts at 125–150 °C, the direct 5‐arylation of thiazoles, thiophenes, or furans
    某些醚,例如环戊基甲基醚和二正丁基醚,可以被认为是比N,N-二甲基乙酰胺(DMAc)或DMF更“绿色”的溶剂,可有利地用于钯催化的杂芳族化合物的直接芳基化。在125-150°C的条件下,在存在此类醚和仅0.5-1 mol%的钯催化剂的情况下,通过使用芳基溴化物作为偶联伙伴,噻唑,噻吩或呋喃的直接5-芳基化反应将以中等至高收率进行。
  • [EN] PYRIMIDINONE DERIVATIVES AND USES THEREOF TO NEUTRALIZE THE BIOLOGICAL ACTIVITY OF CHEMOKINES<br/>[FR] DÉRIVÉS DE PYRIMIDINONE ET LEURS UTILISATIONS POUR NEUTRALISER L'ACTIVITÉ BIOLOGIQUE DES CHIMIOKINES
    申请人:CENTRE NATIONAL DE LA RECHERCHE SCIENT - CNRS -
    公开号:WO2018011376A1
    公开(公告)日:2018-01-18
    A subject of the present invention is a compound having the general formula (I) a pharmaceutically acceptable salt thereof or a tautomeric form thereof, wherein A, B3, B4, B5, Y, X, B1 and B2 are as defined in any one of claims 1 to 10. Another subject of the invention is the compound as defined above for use as a medicament, in particular for preventing and/or treating inflammation and inflammatory diseases, immune and auto-immune diseases, pain related diseases, genetic diseases and/or cancer.
    本发明的一个主题是具有通式(I)的化合物,其药学上可接受的盐或其互变异构体,其中A、B3、B4、B5、Y、X、B1和B2如权利要求1至10中的任一所定义。本发明的另一个主题是上述定义的化合物作为药物的用途,特别用于预防和/或治疗炎症和炎症性疾病、免疫和自身免疫疾病、与疼痛有关的疾病、遗传疾病和/或癌症。
查看更多